MedTrace Logo

Valvular Heart Disease in Jiangxi Province

NCT05523193 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1052

Last updated 2022-08-31

No results posted yet for this study

Summary

Study Title: A real-world study of valvular heart disease in Jiangxi Province

Research Objectives:

① Main objectives: To examine the current incidence of valvular heart disease in Jiangxi Province, to establish a "Formal treatment model" for patients with valvular heart disease, and to manage the collection of diagnostic, therapeutic and prognostic data on patients.

② Secondary objective: To investigate the composite of all-cause mortality, disabling stroke, permanent pacemaker implantation, and moderate or greater valve regurgitation in the "Formal treatment model" group and the "Conventional treatment model" group. The Conventional group was matched to patients who were not in the " Formal treatment model " during the same period.

Design type: a prospective, observational, real-world study (at least 1.5 years). No pre-established fixed treatment protocols, only a Formal treatment model,with all treatment choices made entirely by clinicians following relevant textbooks, expert consensus on clinical guidelines, and based on the patient's condition.

Subjects: All patients with moderate to severe heart valve disease were collected from the Second Affiliated Hospital of Nanchang University and hospitals at all levels in Jiangxi Province from September 2022 to September 2023.

Conditions

  • Valvular Heart Disease
  • Treatment Adherence and Compliance

Interventions

OTHER

Formal treatment model

Formal treatment model , no further surgery or minimally invasive treatment was performed

Sponsors & Collaborators

  • Xiao Huang

    lead OTHER

Principal Investigators

  • Yanqing Wu, President · Second Affiliated Hospital of Nanchang University

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-08-01
Primary Completion
2023-08-31
Completion
2024-08-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05523193 on ClinicalTrials.gov